(Q47904576)

English

Safety, tolerability and immunogenicity of new formulations of the Plasmodium falciparum malaria peptide vaccine SPf66 combined with the immunological adjuvant QS-21.

scientific article published in May 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12009282%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Safety, tolerability and immunogenicity of new formulations of the Plasmodium falciparum malaria peptide vaccine SPf66 combined with the immunological adjuvant QS-21 (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12009282%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Plasmodium falciparum

0 references

0 references

Plasmodium falciparum malaria

1 reference

based on heuristic

inferred from title

malaria vaccine

1 reference

based on heuristic

inferred from title

Arnoldo Barbosa

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12009282%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Manuel-Elkin Patarroyo

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12009282%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12009282%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

9

object named as

Gerd Pluschke

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12009282%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

author name string

Oscar Kashala

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12009282%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Roberto Amador

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12009282%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Maria V Valero

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12009282%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Beatrice Nickel

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12009282%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Claudia A Daubenberger

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12009282%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Fanny Guzman

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12009282%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

language of work or name

0 references

publication date

1 May 2002

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12009282%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12009282%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12009282%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

2263-2277

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12009282%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

17-18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12009282%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Malaria vaccine development: current status

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of protective immunity against experimental infection with malaria using synthetic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and immunogenicity of the synthetic malaria vaccine SPf66 in a large field trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The first field trials of the chemically synthesized malaria vaccine SPf66: safety, immunogenicity and protectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccination with SPf66, a chemically synthesised vaccine, against Plasmodium falciparum malaria in Colombia.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety, immunogenicity and protective effect of the SPf66 malaria synthetic vaccine against Plasmodium falciparum infection in a randomized double-blind placebo-controlled field trial in an endemic area of Ecuador

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A population-based clinical trial with the SPf66 synthetic Plasmodium falciparum malaria vaccine in Venezuela

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

SPf66, a chemically synthesized subunit malaria vaccine, is safe and immunogenic in Tanzanians exposed to intense malaria transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of the SPf66 vaccine for malaria control when delivered through the EPI scheme in Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. Shoklo SPf66 Malaria Vaccine Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of SPf66 malaria vaccine efficacy in Brazil.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I safety and immunogenicity testing of clinical lots of the synthetic Plasmodium falciparum vaccine SPf66 produced under good manufacturing procedure conditions in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The SPf66 Malaria Vaccine: What is the Evidence for Efficacy?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of multiple Plasmodium falciparum infections in Tanzanian children during the phase III trial of the malaria vaccine SPf66.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction in the mean number of Plasmodium falciparum genotypes in Gambian children immunized with the malaria vaccine SPf66.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Immune responses to Plasmodium falciparum antigens during a malaria vaccine trial in Tanzanian children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

QS-21: a water-soluble triterpene glycoside adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthetic malaria peptide vaccine elicits high levels of antibodies in vaccinees of defined HLA genotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Studies on the humoral immune response to a synthetic vaccine against Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of adjuvants and delivery systems in modulation of immune response to vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Descriptive epidemiology of adverse events after immunization: reports to the Vaccine Adverse Event Reporting System (VAERS), 1991-1994.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Major adverse reactions to yeast-derived hepatitis B vaccines--a review.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Two patterns of systemic immediate-type reactions to Japanese encephalitis vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccines against the blood stages of falciparum malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

T-cell control of immunity to the asexual blood stages of the malaria parasite.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Rhoptry-associated protein 1-binding monoclonal antibody raised against a heterologous peptide sequence inhibits Plasmodium falciparum growth in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0264-410X(02)00115-9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12009282%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12009282%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47904576&oldid=1726614467"